Seer (SEER) Competitors $2.06 -0.04 (-1.90%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$2.06 0.00 (0.00%) As of 03/3/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SEER vs. LAB, ALNT, EYPT, AEHR, QTRX, QSI, NAUT, KEQU, FEIM, and RPIDShould you be buying Seer stock or one of its competitors? The main competitors of Seer include Standard BioTools (LAB), Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Frequency Electronics (FEIM), and Rapid Micro Biosystems (RPID). These companies are all part of the "measuring and control equipment" industry. Seer vs. Standard BioTools Allient EyePoint Pharmaceuticals Aehr Test Systems Quanterix Quantum-Si Nautilus Biotechnology Kewaunee Scientific Frequency Electronics Rapid Micro Biosystems Standard BioTools (NASDAQ:LAB) and Seer (NASDAQ:SEER) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, community ranking, risk, analyst recommendations and media sentiment. Is LAB or SEER more profitable? Standard BioTools has a net margin of -79.92% compared to Seer's net margin of -565.83%. Seer's return on equity of -21.96% beat Standard BioTools' return on equity.Company Net Margins Return on Equity Return on Assets Standard BioTools-79.92% -27.05% -15.52% Seer -565.83%-21.96%-19.85% Does the MarketBeat Community favor LAB or SEER? Standard BioTools received 2 more outperform votes than Seer when rated by MarketBeat users. Likewise, 83.33% of users gave Standard BioTools an outperform vote while only 13.64% of users gave Seer an outperform vote. CompanyUnderperformOutperformStandard BioToolsOutperform Votes583.33% Underperform Votes116.67%SeerOutperform Votes313.64%Underperform Votes1986.36% Which has preferable valuation and earnings, LAB or SEER? Standard BioTools has higher revenue and earnings than Seer. Standard BioTools is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStandard BioTools$174.43M2.16-$74.66M-$0.55-1.84Seer$14.18M8.57-$86.28M-$1.39-1.48 Do analysts rate LAB or SEER? Standard BioTools currently has a consensus target price of $2.88, indicating a potential upside of 184.65%. Seer has a consensus target price of $3.00, indicating a potential upside of 45.63%. Given Standard BioTools' stronger consensus rating and higher possible upside, research analysts plainly believe Standard BioTools is more favorable than Seer.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Standard BioTools 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Seer 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media favor LAB or SEER? In the previous week, Standard BioTools had 6 more articles in the media than Seer. MarketBeat recorded 21 mentions for Standard BioTools and 15 mentions for Seer. Standard BioTools' average media sentiment score of 0.37 beat Seer's score of -0.11 indicating that Standard BioTools is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Standard BioTools 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Seer 2 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more risk & volatility, LAB or SEER? Standard BioTools has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Comparatively, Seer has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Do institutionals and insiders believe in LAB or SEER? 53.7% of Standard BioTools shares are owned by institutional investors. Comparatively, 75.2% of Seer shares are owned by institutional investors. 53.1% of Standard BioTools shares are owned by insiders. Comparatively, 15.0% of Seer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryStandard BioTools beats Seer on 14 of the 18 factors compared between the two stocks. Get Seer News Delivered to You Automatically Sign up to receive the latest news and ratings for SEER and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SEER vs. The Competition Export to ExcelMetricSeerAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$121.47M$4.81B$5.81B$8.41BDividend YieldN/A0.48%4.75%3.98%P/E Ratio-1.5827.7224.9519.25Price / Sales8.574.51375.55110.22Price / CashN/A36.4538.0534.58Price / Book0.331.847.334.28Net Income-$86.28M-$83.57M$3.18B$247.04M7 Day Performance-8.44%-7.87%-2.87%-3.25%1 Month Performance-9.65%-13.98%-6.77%-6.55%1 Year Performance7.29%-33.15%12.32%4.01% Seer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SEERSeer1.7563 of 5 stars$2.06-1.9%$3.00+45.6%+13.2%$121.47M$14.18M-1.58160High Trading VolumeLABStandard BioTools2.4881 of 5 stars$1.33+2.3%$2.88+116.2%-59.6%$495.11M$106.34M-1.87620Analyst RevisionALNTAllient4.2803 of 5 stars$25.86-2.7%$31.00+19.9%-18.0%$435.61M$548.96M29.392,287Positive NewsEYPTEyePoint Pharmaceuticals1.5164 of 5 stars$5.91-3.9%$26.63+350.5%-79.6%$403.36M$45.71M-2.96120Upcoming EarningsAEHRAehr Test Systems3.0543 of 5 stars$10.50-8.1%$25.00+138.1%-49.9%$311.98M$50.74M14.0090QTRXQuanterix1.8047 of 5 stars$8.06+6.8%$23.25+188.5%-73.7%$310.50M$132.53M-7.60460Upcoming EarningsShort Interest ↑Gap UpQSIQuantum-Si2.3158 of 5 stars$1.62-5.3%$3.42+110.9%-29.7%$231.19M$1.08M-2.53150News CoverageNAUTNautilus Biotechnology2.3169 of 5 stars$1.50-2.6%$3.58+138.9%-54.4%$188.34MN/A-2.68130Gap UpKEQUKewaunee Scientific1.677 of 5 stars$54.25-0.7%N/A+80.5%$155.70M$203.76M8.601,006FEIMFrequency Electronics2.4786 of 5 stars$15.45-3.0%N/A+41.0%$148.49M$60.19M18.84200Positive NewsRPIDRapid Micro Biosystems2.614 of 5 stars$2.80-12.8%$8.00+185.7%+164.3%$120.48M$22.52M-2.50200Earnings Report Related Companies and Tools Related Companies Standard BioTools Alternatives Allient Alternatives EyePoint Pharmaceuticals Alternatives Aehr Test Systems Alternatives Quanterix Alternatives Quantum-Si Alternatives Nautilus Biotechnology Alternatives Kewaunee Scientific Alternatives Frequency Electronics Alternatives Rapid Micro Biosystems Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SEER) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seer, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
